History
Ischemic heart disease refers to a condition in which the coronary arteries, which supply oxygen and nutrients to the heart, become narrowed or blocked so that the heart muscle does not receive as much blood as it needs. The term coronary artery disease (CAD) is also widely used in the same context, and in everyday terms it is easy to understand by thinking of angina and myocardial infarction. In the past, it was often explained with a simple picture of "blood vessels clogging like grease buildup," but over time it has become increasingly clear that this disease is a chronic disease arising not only from "fat accumulation" but from the accumulation of "inflammation and damage in the vessel wall."
From the mid-20th century onward, as smoking, high-calorie diets, and sedentary lifestyles increased and average life expectancy lengthened, ischemic heart disease became established as a leading cause of death in many countries. At the same time, as it was repeatedly confirmed that managing risk factors (blood pressure, blood glucose, cholesterol, smoking, etc.) reduces its occurrence, the concept of prevention entered the center of medicine. Diagnostic and treatment technologies also advanced together. Acute myocardial infarction could be detected quickly with the electrocardiogram (ECG), and the location of vessel narrowing could be confirmed directly with coronary angiography.
In terms of treatment, percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) became widespread, and stent technology advanced to drug-eluting stents (DES). As cholesterol treatment such as statins and antiplatelet agents became commonplace, acute-phase mortality and recurrence rates decreased. Recent studies emphasize that long-term prognosis improves when the condition of blood vessels throughout the body, inflammation, metabolic diseases, and lifestyle are managed together. In other words, modern management of ischemic heart disease centers not only on emergency treatment but also on "long-term management" that lowers lifetime risk.
Causes
The most common cause of ischemic heart disease is atherosclerosis. Cholesterol and inflammatory cells accumulate inside the vessel wall to form plaque (atheromatous plaque), and as this plaque grows, the coronary arteries gradually narrow. When a blood vessel narrows slowly, blood flow becomes insufficient when the heart demands more oxygen, such as during exercise or stress, causing chest pain, which is commonly called angina.
A more dangerous situation is when the surface of the plaque suddenly tears or erodes. At that point, blood sticks to the damaged surface and forms a clot (thrombus), and the vessel can become blocked in an instant. Such an acute situation is called acute coronary syndrome (ACS), and its result can be myocardial infarction (MI).
The "determining force" behind the cause lies in risk factors. Smoking, hypertension, diabetes, dyslipidemia, obesity, lack of exercise, lack of sleep, and excessive drinking promote the formation and worsening of plaque. Diet is also important: excessive intake of saturated and trans fats and a lack of vegetables, fruits, and dietary fiber can worsen blood lipids and the inflammatory state. In recent studies, vascular inflammation is treated as one of the key factors explaining "residual risk," and it is suggested that in some patients certain lipids (e.g., lipoprotein(a)) can be an important clue.
Genetic Epidemiology
Ischemic heart disease is closely linked to lifestyle, but even among people with the same lifestyle, the timing of onset and severity differ greatly. One of the factors that explains this difference is heredity. If someone in the family experienced myocardial infarction or angina at a relatively young age, you may also be at higher risk. This is partly because families share similar dietary habits and environments, but in reality, accumulated genetic differences related to how cholesterol is processed, the strength of inflammatory responses, the recovery capacity of the vascular endothelium, and the tendency to form blood clots can change the risk.
Heredity more commonly works not through a single gene being "the cause," but through many variants of small effect adding up to raise overall risk. For this reason, genetic testing is used not to make a diagnosis on its own but as reference material to gauge "whether lifetime risk is on the high side." Recent studies emphasize that even if genetic risk is high, the risk of actual events such as myocardial infarction can be reduced considerably when basic management—quitting smoking, weight management, regular exercise, and control of blood pressure, blood glucose, and lipids—is carried out well. This means that heredity may be an "uneven playing field," but lifestyle and treatment can change the outcome of the game.
General Epidemiology
Ischemic heart disease is very common worldwide and is a leading cause of death in many countries. Because plaque has more time to accumulate in the coronary arteries as people age, its prevalence tends to increase with age, and it tends to appear at a relatively younger age in men, but in women too the risk increases after menopause. It is also important from a public health perspective that the disease does not always present only with the typical symptom of "chest pain," so its detection can be delayed.
At the population level, smoking rates and the prevalence of obesity, diabetes, hypertension, and dyslipidemia strongly determine the occurrence of ischemic heart disease. Lifestyle patterns in which walking time decreases because of urbanization and intake of processed foods and sugar increases act to raise risk. Conversely, when smoking-cessation policies, widespread treatment of blood pressure and cholesterol, and emergency treatment (rapid reperfusion therapy for myocardial infarction) spread, mortality decreases.
Recent studies report that factors other than "traditional risk factors," such as air pollution, sleep apnea, chronic inflammatory diseases, and certain cancer treatments, can also increase risk. However, the key things the general public can practice are still quitting smoking, healthy eating, regular exercise, appropriate body weight, and consistent management of blood pressure, blood glucose, and lipid levels.
Pathogenesis
The essence of ischemic heart disease is an imbalance between "the amount of oxygen the heart muscle demands" and "the amount of oxygen the coronary arteries can supply." During exercise or stress, the heart beats faster and needs more oxygen, but if the coronary arteries are narrowed, supply cannot keep up, causing chest pain or shortness of breath.
The process by which plaque forms is not simple "fat accumulation" but "accumulation of an inflammatory response." Factors such as smoking, hypertension, diabetes, and dyslipidemia damage the vascular endothelium or impair its function, and LDL cholesterol seeps into the vessel wall through the gaps. Immune cells then gather, macrophages that have taken up cholesterol become foam cells, and the lesion grows into a plaque mixed with fibrous tissue and calcium.
An important point in this process is the "nature" of the plaque. Some plaques are hard and stable and narrow the vessel gradually, causing angina, while others have a thin cap and an unstable interior and can tear easily. When a plaque ruptures, a clot forms rapidly, the vessel becomes blocked, and this can lead to myocardial infarction. Recent studies emphasize that ischemic symptoms can occur even without severe blockage of the large vessels, due to problems such as microvascular dysfunction or vasospasm, and in such cases the diagnostic and treatment approach may differ.
Symptoms
The most typical symptom is chest pain or a feeling of pressure in the chest. Many people describe it as "a feeling of tightness or crushing in the chest," and it is readily triggered by exercise, overwork, cold, or emotional stress. The pain may be felt in the center or left side of the chest, and it may spread to the left arm, shoulder, neck, jaw, back, or the pit of the stomach. In some cases it feels like heartburn or indigestion and is mistaken for a gastrointestinal problem.
Shortness of breath (dyspnea) is as common a symptom as chest pain, and especially in older adults, women, and patients with diabetes, shortness of breath or fatigue may appear before chest pain. Cold sweats, nausea, vomiting, dizziness, extreme fatigue, and fainting may accompany it, and if such symptoms begin suddenly or gradually worsen, acute coronary syndrome should be suspected.
In acute myocardial infarction, the pain often lasts more than 10 minutes or does not improve with rest, and if chest discomfort of an unusual intensity newly develops, immediate emergency evaluation is needed. Even if the symptoms are not typical, if they are suspicious, it is important to get an emergency evaluation without hesitation.
Signs
Signs are objective clues confirmed by examination or testing. Ischemic heart disease is difficult to confirm based on physical examination findings alone, but in acute situations several signs can appear together. The most important test is the electrocardiogram (ECG), which may show ischemic findings such as ST changes or T-wave changes, and certain forms of ST elevation strongly suggest acute myocardial infarction.
In blood tests, high-sensitivity cardiac troponin (hs-cTn) is key. When heart muscle damage occurs, its level rises, and because it changes over time, a rising trend is usually confirmed by repeated measurement. If the heart weakens and heart failure accompanies the condition, findings such as crackles in the lungs, decreased oxygen saturation, leg swelling, low blood pressure, and rapid heart rate may appear. On imaging, regional wall motion abnormalities may be seen on echocardiography, or narrowing and plaque may be confirmed on CT coronary angiography.
Screening
The most important way to detect ischemic heart disease early in "people without symptoms" is risk factor screening rather than any particular imaging test. Blood pressure measurement, fasting blood glucose or glycated hemoglobin (HbA1c), cholesterol tests, smoking status, body weight and waist circumference, and checking family history are the basics. If risk is found to be high in this process, starting lifestyle correction and, if needed, drug treatment produces the greatest preventive effect.
Test-based screening is considered "selectively according to risk level" rather than being recommended uniformly for everyone. In asymptomatic low-risk groups, excessive testing (e.g., CT, exercise stress testing) can lead to unnecessary additional tests and anxiety. Conversely, for people with many risk factors or with vague but recurring symptoms, a physician can choose an appropriate noninvasive test after assessing their risk.
Recent studies discuss that the coronary artery calcium score (CAC) can help reclassify risk in some people. However, the most important principle is to maintain "a lifestyle and treatment that consistently lower risk factors" rather than "being reassured by tests."
Diagnosis
Diagnosis usually proceeds in the sequence "identifying symptoms and risk factors → basic tests → detailed tests if needed." When chest pain is suspected in the emergency room, a 12-lead electrocardiogram (ECG) is performed immediately to check for acute myocardial infarction, and at the same time high-sensitivity cardiac troponin (hs-cTn) is measured repeatedly to evaluate heart muscle damage. It is also important to consider dangerous differential diagnoses (e.g., aortic dissection, pulmonary embolism) at the same time.
When symptoms are chronic or stable, noninvasive tests become central. The exercise treadmill test is widely accessible but has limitations in accuracy, so depending on the situation, stress echocardiography, nuclear perfusion imaging (SPECT), cardiac magnetic resonance imaging (cardiac MRI), and others are used. To view anatomical information, CT coronary angiography (CTCA) may be used.
If noninvasive tests show high-risk findings or acute coronary syndrome is strongly suspected, the diagnosis is confirmed with invasive coronary angiography, which can proceed directly to percutaneous coronary intervention if needed. Recent studies emphasize the importance of functional testing to identify cases in which symptoms persist even though the vessels are not significantly blocked (microvascular ischemia, vasospasm).
Treatment
Treatment has two goals. The first is to reduce symptoms such as chest pain and shortness of breath so that daily life is possible, and the second is to lower the risk of major events such as myocardial infarction and sudden death. To achieve this, lifestyle, medications, and procedures or surgery are used together. Lifestyle is fundamental at every stage. Quitting smoking can be expected to have the strongest effect, and a diet centered on vegetables, fruits, whole grains, nuts, and legumes is recommended, reducing saturated and trans fats, excessive sugar and salty foods, and processed foods. Regular exercise, maintaining an appropriate weight, and sufficient sleep are also important.
Drug treatment is combined according to the patient's condition. For symptom relief, nitrates, beta blockers, calcium channel blockers, and others may be used. For prevention of recurrence, antiplatelet agents, lipid-lowering drugs (statins, etc.), and, if needed, blood pressure medications and diabetes medications are included. Recent studies discuss that in some patients, strategies to lower inflammation may help further reduce "residual risk," and they emphasize that medications for metabolic diseases can help reduce cardiovascular risk.
Procedures and surgery are not needed by everyone, and their benefits differ by situation. Percutaneous coronary intervention (PCI) can be a very important treatment in acute myocardial infarction, while in chronic stable angina it is chosen mainly with the goal of "symptom improvement." Coronary artery bypass grafting (CABG) can help long-term prognosis when multiple vessels are extensively narrowed or with certain lesion types, so the decision is made by considering the individual's lesions and comorbidities together.
Prognosis
The prognosis depends on how extensively and how severely the coronary arteries are involved, whether the person has had a myocardial infarction, how well heart function is preserved, and whether there are comorbidities such as diabetes, kidney disease, or heart failure. Even with the same statement "the coronary arteries have narrowed," the risk differs between a case with mild narrowing in a few places and a case in which the major vessels are severely narrowed in several places.
As standard treatment has advanced, many people have become able to live stably for long periods, but it is not a disease in which the risk of recurrence disappears completely. Therefore, continuing drug treatment, controlling risk factors, and regular follow-up determine the long-term prognosis. Recent studies emphasize that events can occur even in people whose symptoms appear stable if risk factors remain, so strategies of regularly checking targets such as LDL cholesterol, blood pressure, and blood glucose and adjusting the intensity of treatment are emphasized.
Prevention
Prevention is broadly divided into primary prevention (prevention before the disease exists) and secondary prevention (preventing recurrence in people who already have the disease). The key to primary prevention is quitting smoking, healthy eating, regular exercise, appropriate body weight, sufficient sleep, and regularly checking blood pressure, blood glucose, and cholesterol and treating them if needed. In general, about 150 minutes per week of moderate-intensity aerobic exercise and muscle-strengthening exercise at least twice a week are helpful.
In secondary prevention, the importance of medications becomes greater. Antiplatelet agents, lipid-lowering drugs including statins, blood pressure medications, diabetes medications, and others are used to lower the risk of recurrence, and cardiac rehabilitation systematically provides exercise, diet, stress management, and education, helping to lower the risk of recurrence and improve quality of life. Recent studies repeatedly emphasize that maintaining lifestyle changes and drug treatment together "consistently" leads to the greatest benefit over the long term.